Standout Papers
Immediate Impact
5 from Science/Nature 64 standout
Citing Papers
Catalytic Asymmetric Construction of Chiral Polysubstituted 3-Azabicyclo[3.1.1]heptanes by Copper-Catalyzed Stereoselective Formal [4π+2σ] Cycloaddition
2024 Standout
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Works of Daniel Brigham being referenced
Discovery and optimization of a highly efficacious class of 5-aryl-2-aminopyridines as FMS-like tyrosine kinase 3 (FLT3) inhibitors
2015
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daniel Brigham | 378 | 172 | 280 | 10 | 703 | |
| Angelene M. Cantwell | 370 | 111 | 286 | 23 | 828 | |
| CC Uphoff | 172 | 50 | 233 | 12 | 580 | |
| Richard Stillion | 121 | 83 | 203 | 9 | 700 | |
| Michael Paran | 242 | 69 | 205 | 14 | 628 | |
| Afsaneh Keyhani | 103 | 43 | 217 | 18 | 591 | |
| Laurie Sower | 204 | 67 | 335 | 19 | 774 | |
| Dharma R. Thapa | 196 | 189 | 161 | 14 | 629 | |
| Kurt Lackovic | 104 | 45 | 347 | 23 | 818 | |
| C. Kempf | 188 | 100 | 376 | 11 | 769 | |
| Noboru Tamura | 321 | 220 | 150 | 14 | 810 |
All Works
Loading papers...